149 related articles for article (PubMed ID: 38509841)
1. Induction of psoriatic scalp and nail lesions in a patient treated with Ofatumumab: A potential autoimmune dysregulation induced by anti-CD 20 therapy.
Herzum A; Orsi SM; Ciccarese G; Occella C; Viglizzo G
Skin Res Technol; 2024 Mar; 30(3):e13662. PubMed ID: 38509841
[No Abstract] [Full Text] [Related]
2. Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study.
Thaçi D; Unnebrink K; Sundaram M; Sood S; Yamaguchi Y
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):353-360. PubMed ID: 24846518
[TBL] [Abstract][Full Text] [Related]
3. Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.
Mishra V; Daniel RC; Elmets CA; Levin A; Elewski BE
J Drugs Dermatol; 2013 Jan; 12(1):16-7. PubMed ID: 23377322
[No Abstract] [Full Text] [Related]
4. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
[TBL] [Abstract][Full Text] [Related]
5. Intramatricial injection of anti-interleukin-17A antibody for six patients with nail psoriasis.
He F; Long FY; Zhang ZQ; Xia RY; Lu Y; Yin ZQ
Clin Exp Dermatol; 2022 Feb; 47(2):432-433. PubMed ID: 34510518
[No Abstract] [Full Text] [Related]
6. Clinical improvement in psoriatic nail disease and psoriatic arthritis with tildrakizumab treatment.
Ismail FF; May J; Moi J; Sinclair R
Dermatol Ther; 2020 Mar; 33(2):e13216. PubMed ID: 31899569
[No Abstract] [Full Text] [Related]
7. Biological therapy and nail psoriasis.
Lawry M
Dermatol Ther; 2007; 20(1):60-7. PubMed ID: 17403261
[TBL] [Abstract][Full Text] [Related]
8. Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis.
Langley RG; Rich P; Menter A; Krueger G; Goldblum O; Dutronc Y; Zhu B; Wei H; Cameron GS; Heffernan MP
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1763-70. PubMed ID: 25693783
[TBL] [Abstract][Full Text] [Related]
9. The Brigham Scalp Nail Inverse Palmoplantar Psoriasis Composite Index (B-SNIPI): a novel index to measure all non-plaque psoriasis subsets.
Patel M; Liu SW; Qureshi A; Merola JF
J Rheumatol; 2014 Jun; 41(6):1230-2. PubMed ID: 24882859
[TBL] [Abstract][Full Text] [Related]
10. Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab.
Al-Mutairi N; Nour T; Al-Rqobah D
Expert Opin Biol Ther; 2013 May; 13(5):625-9. PubMed ID: 23527597
[TBL] [Abstract][Full Text] [Related]
11. Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics.
Bardazzi F; Starace M; Bruni F; Magnano M; Piraccini BM; Alessandrini A
Acta Derm Venereol; 2019 May; 99(6):516-523. PubMed ID: 30521057
[TBL] [Abstract][Full Text] [Related]
12. Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients.
Vitiello M; Tosti A; Abuchar A; Zaiac M; Kerdel FA
Int J Dermatol; 2013 Mar; 52(3):358-62. PubMed ID: 23330782
[No Abstract] [Full Text] [Related]
13. Marked improvement in nail psoriasis during treatment with adalimumab.
Irla N; Yawalkar N
Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial.
Lin YK; See LC; Huang YH; Chang YC; Tsou TC; Lin TY; Lin NL
Phytomedicine; 2014 Jun; 21(7):1015-20. PubMed ID: 24680615
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the efficacy of Intense Pulsed Light (I.P.L.) versus Photo-Dynamic Therapy (P.D.T.) with methylene-blue in the treatment of psoriatic nails.
Shaheen MA; Dakhli AO; Hassen SI
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103298. PubMed ID: 36682430
[TBL] [Abstract][Full Text] [Related]
17. Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis.
Rich P; Goldblum O; Disch D; Lin CY; Merola JF; Elewski B
J Drugs Dermatol; 2020 Aug; 19(8):741-746. PubMed ID: 32845588
[TBL] [Abstract][Full Text] [Related]
18. Influence of psoriatic arthritis on the efficacy of adalimumab and on the treatment response of other markers of psoriasis burden: subanalysis of the BELIEVE study.
Paul C; van de Kerkhof P; Puig L; Unnebrink K; Goldblum O; Thaçi D
Eur J Dermatol; 2012; 22(6):762-9. PubMed ID: 23178916
[TBL] [Abstract][Full Text] [Related]
19. Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis.
Wells LE; Evans T; Hilton R; Wine Lee L; Ruth N
Pediatr Dermatol; 2019 May; 36(3):384-385. PubMed ID: 30811618
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
